CT disorders and Vasculitides Flashcards
anti-nuclear Ab test
NOT SPECIFIC, indirect immunofluorescence, not used to differentiate types of autoimmune diseases
Populations at risk for autoimmune dz
female prevalence, minority populations
What type of hypersensitivity reaction is SLE?
Type III, autoab to nuclear ag
Pericarditis presentation
substernal, constant, “crushing” chest pain worsens with inspiration and in supine position, pericardial friction rub, diffuse ST elevation
Malar rash pattern
erythematous eruption over cheeks and nasal bridge that spares nasolabial folds
SLE serology
+ANA, +anti-dsDNA, +anti-smith, low C3 and C4 due to increased consumption
Libman-Sacks Endocarditis general patho
Immune complexes deposit on heart valves
SLE treatment regimen
avoid sun exposure, NSAIDS, glucocorticoids, hydroxychloroquine
Cause of mortality in early years of SLE
infections with opportunistic organisms, kidney or CNS dz
Cause of mortality in later years of SLE
accelerated atherosclerosis, thromboembolic events and MI
SLE preventative measures and management
minimize risk factors for atherosclerosis, avoid smoking, influenza and pneumococcal vaccine, preventative CA screening, monitor for avascular necrosis and osteoporosis with corticosteroid use
Type I Antiphospholipid Ab
causes false-positive for syphilis
Type II Antiphospholipid Ab
lupus anticoagulant, risk factor for venous and arterial thrombosis and miscarriage, increases aPTT
Type III Antiphospholipid Ab
anti-cardiolipin antibodies, Beta2GPI
When should Abs for APS be measured to diagnose?
two occasions 12 weeks apart
Treatment for APS
indefinite coagulation
DDX for thrombosis
APS, protein S and protein C deficiency, anti-thrombin deficiency, FactorV Leiden deficiency, sepsis, DIC, TTP
SLE/APS retinopathy
cotton wool spots
DDX for cotton wool spots
hypertension, diabetes, ischemia, infection, trauma, idiopathic
Medications associated with lupus-like syndrome
hydralazine, isoniazid, minocycline, TNF inhibitor, methyldopa, quinidine, procainamide, Sulfa abx
DDx for DLE
discoid lupus, tinea infection (ring worm), psoriasis, morphea
Hallmarks of scleroderma
thickening and hardening of skin, fibrosis of organs, dry skin due to obliteration of eccrine sweat and sebaceous glands
Multisystem affects of SSc
lungs, GI, kidney, MSK, Raynaud phenomenon, hyper or hypopigmentation
Localized SSc is seen in what population?
children
Localized SSc presentation
discreet areas of discolored skin induration, NOT systemic, no Raynaud’s, morphea patches
Limited SSc presentation
CREST - Calcinosis cutitis, raynaud’s, esophageal dismotitlity, sclerodactyly, telangiectasia; pulmonary HTN
Diffuse SSc presentation
systemic, early and progressive internal organ involvement resulting in interstitial lung disease and renal crises
Phases of Diffuse SSc
Inflammatory edematous phase then fibrotic; cutaneous manifestations will cause impaired sweating and loss of body hair, fibrosis of joints
Skin manifestations of SSc
hyper/hypopigmented, dry/itchy skin, masklike facies, microstomia, perioral furrowing, calcium deposits
Primary cause of M&M in SSc
pulmonology manifestations
Key pulmonary manifestations of SSc
aspiration pneumonia, interstitial lung disease, pulmonary artery hypertension
Common pulmonary manifestation of Diffuse SSc
Interstitial lung disease, chronic dry cough, dyspnea, rales
Common pulmonary manifestation of Limited SSc
pulmonary artery hypertension; right heart cath to measure pressure; sxs include dyspnea, syncope, angina, right heart failure
Common renal manifestations of SSc
CKD, Renal crises
Renal crisis sxs
malignant hypertension, hemolytic anemia, progressive renal insufficency